Helgadottir, H., Ghiorzo, P., van Doorn, R., Puig i Sardà, S., Levin, M., Kefford, R., . . . Jönsson, G. (2020). Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations.
Citación estilo ChicagoHelgadottir, Hildur, et al. Efficacy of Novel Immunotherapy Regimens in Patients With Metastatic Melanoma With Germline CDKN2A Mutations. 2020.
Cita MLAHelgadottir, Hildur, et al. Efficacy of Novel Immunotherapy Regimens in Patients With Metastatic Melanoma With Germline CDKN2A Mutations. 2020.
Precaución: Estas citas no son 100% exactas.